HUP0303270A3 - Isoxazoline derivatives as anti-depressants, process for their preparation and pharmaceutical compositions containing them - Google Patents

Isoxazoline derivatives as anti-depressants, process for their preparation and pharmaceutical compositions containing them

Info

Publication number
HUP0303270A3
HUP0303270A3 HU0303270A HUP0303270A HUP0303270A3 HU P0303270 A3 HUP0303270 A3 HU P0303270A3 HU 0303270 A HU0303270 A HU 0303270A HU P0303270 A HUP0303270 A HU P0303270A HU P0303270 A3 HUP0303270 A3 HU P0303270A3
Authority
HU
Hungary
Prior art keywords
depressants
preparation
pharmaceutical compositions
compositions containing
isoxazoline derivatives
Prior art date
Application number
HU0303270A
Other languages
English (en)
Hungarian (hu)
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of HUP0303270A2 publication Critical patent/HUP0303270A2/hu
Publication of HUP0303270A3 publication Critical patent/HUP0303270A3/hu

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D261/00Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/20Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings condensed with carbocyclic rings or ring systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Child & Adolescent Psychology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pain & Pain Management (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
HU0303270A 2001-02-21 2002-02-13 Isoxazoline derivatives as anti-depressants, process for their preparation and pharmaceutical compositions containing them HUP0303270A3 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP01200611 2001-02-21
EP01201264 2001-04-05
PCT/EP2002/001567 WO2002066484A1 (en) 2001-02-21 2002-02-13 Isoxazoline derivatives as anti-depressants

Publications (2)

Publication Number Publication Date
HUP0303270A2 HUP0303270A2 (hu) 2004-01-28
HUP0303270A3 true HUP0303270A3 (en) 2007-03-28

Family

ID=26076836

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0303270A HUP0303270A3 (en) 2001-02-21 2002-02-13 Isoxazoline derivatives as anti-depressants, process for their preparation and pharmaceutical compositions containing them

Country Status (32)

Country Link
US (1) US7169786B2 (cs)
EP (1) EP1368358B1 (cs)
JP (1) JP3953424B2 (cs)
KR (1) KR100848898B1 (cs)
CN (1) CN100400540C (cs)
AR (1) AR035685A1 (cs)
AT (1) ATE337322T1 (cs)
AU (1) AU2002244717B2 (cs)
BG (1) BG107984A (cs)
BR (1) BR0207433A (cs)
CA (1) CA2437505C (cs)
CY (1) CY1106448T1 (cs)
CZ (1) CZ20032515A3 (cs)
DE (1) DE60214138T2 (cs)
DK (1) DK1368358T3 (cs)
EA (1) EA006747B1 (cs)
EE (1) EE200300398A (cs)
EG (1) EG23929A (cs)
ES (1) ES2271230T3 (cs)
HR (1) HRP20030647A2 (cs)
HU (1) HUP0303270A3 (cs)
IL (2) IL157470A0 (cs)
MX (1) MXPA03007432A (cs)
MY (1) MY137836A (cs)
NO (1) NO20033700L (cs)
NZ (1) NZ526741A (cs)
PL (1) PL208593B1 (cs)
PT (1) PT1368358E (cs)
SI (1) SI1368358T1 (cs)
SK (1) SK11612003A3 (cs)
TW (1) TWI257392B (cs)
WO (1) WO2002066484A1 (cs)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0203299D0 (en) * 2002-02-12 2002-03-27 Glaxo Group Ltd Novel compounds
NZ536109A (en) * 2002-04-02 2006-06-30 Janssen Pharmaceutica Nv Substituted amino isoxazoline derivatives and their use as anti-depressants
AR040967A1 (es) * 2002-08-12 2005-04-27 Janssen Pharmaceutica Nv Derivados de isoxazolina triciclicos c- sustituidos y su uso como anti- depresivos
ATE456568T1 (de) * 2002-08-15 2010-02-15 Janssen Pharmaceutica Nv Kondensierte heterocyclische isoxazolinderivate und deren verwendung als antidepressiva
ATE387455T1 (de) * 2002-08-21 2008-03-15 Janssen Pharmaceutica Nv C6- und c9-substituierte chromeno(4,3- c)isoxazoline und ihre verwendung als anti- depressiva
BRPI0408136A (pt) * 2003-03-07 2006-03-01 Astellas Pharma Inc derivados heterocìclicos contendo nitrogênio tendo estirila 2,6-dissubstituìda
ES2319539T3 (es) * 2003-09-17 2009-05-08 Janssen Pharmaceutica Nv Compuestos heterociclicos condensados como moduladores del receptor de serotonina.
EP1944306A1 (en) * 2003-09-17 2008-07-16 Janssen Pharmaceutica, N.V. Fused heterocyclic compounds as serotonin receptor modulators
JP2008521771A (ja) * 2004-11-26 2008-06-26 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ 改良された抗精神病活性および抗不安症活性を有するイソキサゾリン−インドール誘導体
WO2008112483A2 (en) 2007-03-09 2008-09-18 Sanofi-Aventis Substituted dihydro and tetrahydro oxazolopyrimidinones, preparation and use thereof
WO2008154442A1 (en) * 2007-06-08 2008-12-18 Helicon Therapeutics, Inc. Therapeutic pyrazoloquinoline urea derivatives
JP2011507835A (ja) 2007-12-21 2011-03-10 アンドレイ・アレクサンドロビッチ・イワシェンコ α−アドレナリン受容体、ドーパミン、ヒスタミン、イミダゾリン及びセロトニン受容体のリガンド並びにその使用
AR078171A1 (es) 2009-09-15 2011-10-19 Sanofi Aventis Dihidrobenzocicloalquiloximetil-oxazolopirimidinonas sustituidas, preparacion y uso de las mismas

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2055011T3 (es) * 1988-09-19 1994-08-16 Akzo Nv Un procedimiento para la preparacion de derivados de tetrahidronaftaleno e indano.
US5880121A (en) * 1996-01-05 1999-03-09 Hoechst Marion Roussel Inc. 4,5-dihydronaphth (1,2-c) isoxazoles and derivatives thereof
CN1082963C (zh) * 1996-04-12 2002-04-17 詹森药业有限公司 异噁唑烷衍生物
HUP9602763A3 (en) * 1996-10-09 1999-05-28 Egyt Gyogyszervegyeszeti Gyar 3-phenyl isoxazole derivatives, process for producing them and pharmaceutical compositions containing the same
CA2346396C (en) * 1998-10-09 2009-04-28 Janssen Pharmaceutica N.V. 4,5-dihydro-isoxazole derivatives and their pharmaceutical use

Also Published As

Publication number Publication date
CY1106448T1 (el) 2011-10-12
NZ526741A (en) 2004-04-30
SK11612003A3 (sk) 2004-04-06
IL157470A (en) 2008-07-08
PL208593B1 (pl) 2011-05-31
HK1065537A1 (zh) 2005-02-25
DK1368358T3 (da) 2007-01-02
ES2271230T3 (es) 2007-04-16
EE200300398A (et) 2003-12-15
CA2437505C (en) 2010-02-09
JP3953424B2 (ja) 2007-08-08
SI1368358T1 (sl) 2007-02-28
NO20033700D0 (no) 2003-08-20
PL363264A1 (en) 2004-11-15
HUP0303270A2 (hu) 2004-01-28
DE60214138T2 (de) 2007-03-29
EA200300915A1 (ru) 2004-06-24
EP1368358A1 (en) 2003-12-10
US7169786B2 (en) 2007-01-30
BR0207433A (pt) 2004-06-01
ATE337322T1 (de) 2006-09-15
BG107984A (bg) 2004-09-30
HRP20030647A2 (en) 2005-06-30
DE60214138D1 (de) 2006-10-05
EP1368358B1 (en) 2006-08-23
JP2004518748A (ja) 2004-06-24
CZ20032515A3 (cs) 2003-12-17
AR035685A1 (es) 2004-06-23
CA2437505A1 (en) 2002-08-29
US20040122037A1 (en) 2004-06-24
CN100400540C (zh) 2008-07-09
MXPA03007432A (es) 2003-11-18
WO2002066484A1 (en) 2002-08-29
CN1492871A (zh) 2004-04-28
KR20030076590A (ko) 2003-09-26
EG23929A (en) 2008-01-14
TWI257392B (en) 2006-07-01
AU2002244717B2 (en) 2007-07-19
EA006747B1 (ru) 2006-04-28
KR100848898B1 (ko) 2008-07-29
NO20033700L (no) 2003-10-21
IL157470A0 (en) 2004-03-28
PT1368358E (pt) 2007-01-31
MY137836A (en) 2009-03-31

Similar Documents

Publication Publication Date Title
HUP0401619A3 (en) Phenethanolamine derivatives, process for their preparation and pharmaceutical composition containing them
HUP0301187A3 (en) Novel benzyl-piperidine-derivatives, process for their preparation and pharmaceutical compositions containing them
HUP0402225A3 (en) Macrolide-compounds, process for their preparation and pharmaceutical compositions containing them
HUP0301069A3 (en) Novel biarylcarboxamides, process for their preparation, pharmaceutical compositions containing them and their use
HUP0402161A3 (en) Nicotin-or isonicotin benzothiazole derivatives, process for their preparation and pharmaceutical compositions containing them
HUP0402264A3 (en) Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines process for preparing them, pharmaceutical compositions containing them and use thereof
HUP0401005A3 (en) Oxazolidinone and/or isoxazoline antibacterials, process for their preparation, their use and pharmaceutical compositions containing them
HUP0300894A3 (en) Substituted beta-carbolines, process for their preparation, pharmaceutical compositions containing them and their use
HUP0400888A3 (en) Substituted cyclohexane-1,4-diamine derivatives, process for their preparation and pharmaceutical compositions containing them
IL156662A0 (en) Oxazolidinone derivatives, process for the preparation thereof and pharmaceutical compositions containing the same
HUP0400040A2 (hu) Szulfonamidok, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények
HUP0303270A3 (en) Isoxazoline derivatives as anti-depressants, process for their preparation and pharmaceutical compositions containing them
HUP0100489A3 (en) New piperidine-4-sulphonamide compounds, process for their preparation and pharmaceutical compositions containing them
HUP0400317A3 (en) Beta-carboline derivatives, process for their preparation, their use and pharmaceutical compositions containing them
HUP0302515A3 (en) Sulfanidothienopyrimidines, process for their preparation and pharmaceutical compositions containing them
AU2003231920A8 (en) Antiinfectve compounds, process for their preparation and pharmaceutical compositions containing them
HUP0204001A3 (en) Substituted aminomethyl-phenyl-cyclohexane derivatives, process for their preparation and pharmaceutical compositions containing them
HUP0401082A3 (en) Substituted 4-aminocyclohexanols, process for their preparation and pharmaceutical compositions containing them
HUP0303105A3 (en) Novel aminocyclohexane derivatives, process for their preparation, pharmaceutical compositions containing them and their use
HUP0303361A3 (en) Substituted 1-aminobutan-3-ol derivatives, process for their preparation and pharmaceutical compositions containing them
SI1118610T1 (en) Benzenesulfonamide derivatives, process for their preparation and pharmaceutical compositions containing them
HUP0301254A3 (en) Novel compounds, process fo their preparation and pharmaceutical compositions containing them
HUP0203859A3 (en) Aminomethyl-phenyl-cyclohexanone derivatives, process for their preparation, pharmaceutical compositions containing them and their use
SI1241169T1 (en) Isoindoloindolone derivatives, process for their preparation and pharmaceutical compositions containing them
HUP0302905A3 (en) Triazolo-epothilone-analogs, process for their preparation and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
FD9A Lapse of provisional protection due to non-payment of fees